NUSATRIP Inc (NUTR) — Institutional Holders, Q2 2026
6 institutional investment managers reported a NUTR position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $2.8M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
NUTR in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
New positions
0
Added to
1
Trimmed
0
Sold out
0
Biggest buyers
- UBS Group AGAdded · +5,000 sh+$45.0K
Biggest sellers
None this quarter.
NUTR 13F holders ranked 1–6 of 6
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS#1 · 149,270 sh | 149,270 | $1.0M | <0.01% | 0.0% |
| 2 | Quadrature Capital Ltd#2 · 108,716 sh | 108,716 | $978.4K | <0.01% | 0.0% |
| 3 | Qube Research & Technologies Ltd#3 · 53,400 sh | 53,400 | $480.6K | <0.01% | 0.0% |
| 4 | Jump Financial#4 · 21,400 sh | 21,400 | $192.6K | <0.01% | 0.0% |
| 5 | UBS Group AG#5 · 17,647 sh | 17,647 | $158.8K | 0.00% | +39.5% |
| 6 | ROYAL BANK OF CANADA#6 · 728 sh | 728 | $0.00 | 0.00% | 0.0% |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.